Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge

scientific article published on 01 May 2019

Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.9758/CPN.2019.17.2.288
P932PMC publication ID6478086
P698PubMed publication ID30905129

P50authorSeung-Hyun KimQ61128582
P2093author name stringMoon-Soo Lee
Yujin Lee
Hyun-Ghang Jeong
Hyun-Chul Youn
P2860cites workUse of the Medication Event Monitoring System to estimate medication compliance in patients with schizophreniaQ24674950
Clinical factors associated with treatment noncompliance in euthymic bipolar patientsQ28138392
Treatment of bipolar disorderQ28290437
Using drug claims data to assess the relationship of medication adherence with hospitalization and costsQ30652843
Interventions for helping patients to follow prescriptions for medicationsQ30868125
A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorderQ34357602
How often is medication taken as prescribed? A novel assessment techniqueQ34525872
Treatment non-adherence in affective disorders.Q34592227
Effect of medication dosing frequency on adherence in chronic diseases.Q34985952
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literatureQ34989186
Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiativeQ35626091
Compliance with tricyclic antidepressants: the value of four different methods of assessmentQ36053927
Identifying and improving non-adherence in bipolar disorders.Q36286408
Predictors of relapse in bipolar disorder: A reviewQ36602532
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature reviewQ37248065
A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.Q37304782
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.Q37581138
REVIEW: Patient, Treatment, and Systems‐Level Factors in Bipolar Disorder Nonadherence: A Summary of the LiteratureQ37807087
A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disordersQ38281460
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior responseQ38381132
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic ReviewQ38852539
Effect of Early Dysphoric Response and Cannabis Use on Discontinuation of Olanzapine or Risperidone in Patients With Early PsychosisQ42908198
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorderQ43467235
A lithium clinic for bipolar patients: 2-year outcome of the first 148 patientsQ43808435
Nonadherence with mood stabilizers: prevalence and predictorsQ43999454
Treatment adherence with antipsychotic medications in bipolar disorderQ44083784
Examining levels of antipsychotic adherence to better understand nonadherenceQ44381856
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insightQ45112266
Predictors of medication adherence in patients with schizophrenia and bipolar disorderQ46927912
Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophreniaQ47721820
Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-studyQ48959238
Treatment nonadherence and neurocognitive impairment in bipolar disorder.Q51868094
Improving treatment adherence in bipolar disorder through psychoeducation.Q51933457
Obesity as a risk factor for antipsychotic noncompliance.Q51944586
Enhancing medication compliance for people with serious mental illness.Q51987498
Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.Q53607270
Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications.Q53861812
Drug therapy: patient compliance.Q54177540
A Cross-sectional Analysis of Patterns and Predictors of Medication Adherence in Bipolar Disorder: Single Center Experience from South India.Q54957701
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatmentQ57612798
Development and validation of a new body-image assessment scaleQ72170682
Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disordersQ72248804
Factors influencing compliance in schizophrenia patientsQ75183935
Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophreniaQ79733628
Relationships among subjective and objective measures of adherence to oral antipsychotic medicationsQ80981074
Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophreniaQ82766513
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectbehavioral neuroscienceQ846566
P304page(s)288-296
P577publication date2019-05-01
P1433published inClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of NeuropsychopharmacologyQ26842559
P1476titleMedication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge
P478volume17

Reverse relations

Q91632734Drug Attitude, Insight, and Patient's Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Surveycites workP2860